| Medical Professionals |
| Dr. Dennis Pank, (No Bio Available). |
| Dr. Peter Berman, Bio Available. Special interests: Clinical child neurology; pediatric epilepsy. Children's Hospital of Philadelphia; Philadelphia, PA, USA. |
| Dr. Neil Buist, (No Bio Available). Oregon Health Sciences University School of Medicince, Pediatrics Department, Doerubecher Children's Hospital; Portland, OR, USA. | Dr. Doug Wallace, (No Bio Available, Photo). Director and Chairman of the Emory University Department of Genetics; Atlanta, GA, USA. |
| Dr. John Dossett, (No Bio Available). The Milton S. Hershey Medical Center, Pennsylvania State University Department of Pediatrics, Division of General Pediatrics; Hershey, PA, USA. |
| Dr. Salvatore DiMauro, Bio Available. Dr. DiMauro conducts biochemical and DNA investigations of human metabolic myopathies, including disorders of glycogen metabolism, lipid metabolism, and mitochondrial function. H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia University P & S; New York, NY, USA. |
| Dr. Armand Miranda, (No Bio available). Dr. Miranda conducts developmental studies in aneural and innervated muscle culture. In Vitro analysis of the expression of mitochondrial encephalomyopathies caused by mitochondrial DNA mutations (Kearns-Sayre Syndrome, Leigh Syndrome, MERRF and MEALS). Expression and localization of dystrophin and dystrophin related protein during myogenesis. Immunochemical analysis of dystrophin in amniocytes, converted to muscle, using a muscle determination gene (MyoD), and evaluation of this method as a diagnostic tool. H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia University P & S; New York, NY, USA. |
| Dr. Daryl DiVivo, Bio Available. Dr. DiVivo conducts biochemical and molecular studies of inherited and acquired metabolic diseases that affect the developing nervous system and muscular system. His research projects focus on mitochondrial disorders and specifically on enzymatic defects of oxidative metabolism. H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Child Neurology Research Laboratories, Columbia University; New York, NY, USA. |
| Dr. Robert C. Vannucci, (No Bio Available). Chief of Division of Pediatric Neurology at The Milton S. Hershey Medical Center, Pennsylvania State University Department of Pediatrics, Division of Neurology; Hershey, PA, USA. |
| Dr. William J. Lovett, (No Bio Available). Fredricksburg Health Center; Fredricksburg, PA, USA. |
| Dr. Richard Haas, Bio Available. Co-director of the MMDC. He is a board certified pediatric neurologist and pediatrician. President of the L.A.S.T Medical Advisory Board. He is nationally known for his basic and clinical work in neurometabolic disease, and has carried out both clinical and bench research on the mitochondrial and metabolic diseases of children for over 20 years. He is a professor at the University of Califomia, San Diego, with joint appointments in the departments of Neurosciences and Pediatrics. The Mitochondrial and Metabolic Disease Center Biochemical Genetics and Metabolism UCSD Medical Center; San Diego, CA, USA |
| Dr. Robert K. Naviaux, MD, PhD, Bio Available. Co-director of the MMDC. He is board certified in intemal medicine and a specialist in biochemical genetics and metabolism. His research experience spans 20 years and embraces the fields of virology, genetics, cancer, and metabolism. Dr. Naviaux has been a practicing physician since 1986. The Mitochondrial and Metabolic Disease Center Biochemical Genetics and Metabolism UCSD Medical Center; San Diego, CA, USA |
| Dr. John M. Shoffner, MD, Bio Available. Scottish Rite Children's Medical Center; Atlanta, GA, USA |
| Dr. Carlos T. Moraes PhD , (No Bio Available). In addition to defining novel mtDNA abnormalities in patients with mitochondrial disorders, Dr. Moraes is interested in understanding the molecular pathogenesis of these mutations. He and his coworkers use a full array of molecular and cell biology techniques to analyze mitochondrial gene expression both in patients' tissues and in transmitochondrial cell lines. He is particularly interested in the consequences of tRNA mutations on mitochondrial protein synthesis. Novel approaches to gene therapy for mitochondrial disorders are also being developed in their laboratory. The Department of Neurology-University of Miami School of Medicine; Miami, Florida, USA. |
| Dr. Thomas Klopstock, (No Bio Available). A medical doctor in the Dept. of Neurology, and particularly interested in mitochondrial diseases. Dr. Klopstock and his associates are doing diagnosis of these diseases by muscle morphology and by molecular genetics. They care for about 30 patients at the moment with mitochondrial diseases, and are currently conducting a therapeutic study in chronic progressive external ophthalmoplegia. Department of Neurology, University of Munich; 81366 Munich; Germany |
